YOUNG JOSEPH R (SVP, Finance, Chief Acct Offcr) sold 23.9% of their position (15K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $435.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/13/2025ACC: 0001193125-25-280792
Officer· SVP, Finance, Chief Acct Offcr
Since May 2021
-15K
Net shares
Net seller
$435.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 25K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−15K
Price / share
$29.06
Trade value
$435.87K
% of position
23.9%
11/11/2025
62.84K→47.84K
Class A Common Stock
Direct
Shares
+10K
Price / share
$3.94
Trade value
$39.40K
% of position
20.9%
11/13/2025
47.84K→57.84K
Total
Net shares
−5K
Net value
-$396.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 11/11/2025 | S · Sale | −15K | $29.06 | $435.87K | 23.9% | 62.84K | 47.84K |
| Class A Common Stock Direct | 11/13/2025 | M · Option Exercise | +10K | $3.94 | $39.40K | 20.9% | 47.84K | 57.84K |
| Total | −5K | -$396.48K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
10K shares
Shares
−10K
Strike price
3.9396
Held after
48.59K
Exercisable
—
11/13/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock10K shares | 11/13/2025 | M · Option Exercise | −10K | 3.9396 | — | 48.59K |